Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

NCT00101335 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Precancerous Condition

Interventions

DRUG: celecoxib

Sponsor

Fox Chase Cancer Center

Collaborators

[object Object]